Weian Song

412 total citations
14 papers, 301 citations indexed

About

Weian Song is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Surgery. According to data from OpenAlex, Weian Song has authored 14 papers receiving a total of 301 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Pulmonary and Respiratory Medicine, 5 papers in Oncology and 4 papers in Surgery. Recurrent topics in Weian Song's work include Lung Cancer Diagnosis and Treatment (7 papers), Lung Cancer Treatments and Mutations (5 papers) and Esophageal Cancer Research and Treatment (4 papers). Weian Song is often cited by papers focused on Lung Cancer Diagnosis and Treatment (7 papers), Lung Cancer Treatments and Mutations (5 papers) and Esophageal Cancer Research and Treatment (4 papers). Weian Song collaborates with scholars based in China and India. Weian Song's co-authors include Xiangyang Chu, Naikang Zhou, Juntang Guo, Chaoyang Liang, Wei Wang, Xiaodong Tian, Yang Liu, Xi Liu, Xiaobin Hou and Zhiqiang Xue and has published in prestigious journals such as SHILAP Revista de lepidopterología, The Annals of Thoracic Surgery and Medicine.

In The Last Decade

Weian Song

14 papers receiving 295 citations

Peers

Weian Song
E Canals Spain
M. Frueh Switzerland
Kate Smith United Kingdom
Stacey Petruzella United States
Weian Song
Citations per year, relative to Weian Song Weian Song (= 1×) peers Daqiang Sun

Countries citing papers authored by Weian Song

Since Specialization
Citations

This map shows the geographic impact of Weian Song's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Weian Song with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Weian Song more than expected).

Fields of papers citing papers by Weian Song

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Weian Song. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Weian Song. The network helps show where Weian Song may publish in the future.

Co-authorship network of co-authors of Weian Song

This figure shows the co-authorship network connecting the top 25 collaborators of Weian Song. A scholar is included among the top collaborators of Weian Song based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Weian Song. Weian Song is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
1.
Yang, Yue, Changguo Chen, Juntao Yang, et al.. (2025). Purine nucleoside phosphorylase dominates Influenza A virus replication and host hyperinflammation through purine salvage. Signal Transduction and Targeted Therapy. 10(1). 191–191. 2 indexed citations
2.
3.
Lu, Jing, et al.. (2023). Three-Field Versus Two-Field Lymphadenectomy in Minimally Invasive Esophagectomy: 3-Year Survival Outcomes of a Randomized Trial. Annals of Surgical Oncology. 30(11). 6730–6736. 5 indexed citations
4.
Wang, Xingtong, Shouyin Di, Siyu Chen, et al.. (2022). Short-term outcomes of neoadjuvant sintilimab with chemotherapy in stage III non-small cell lung cancer: a case series. Translational Cancer Research. 11(6). 1697–1704. 4 indexed citations
5.
Gong, Taiqian, et al.. (2022). 520. EFFICACY AND SAFETY OF NEOADJUVANT CHEMOTHERAPY AND IMMUNOTHERAPY IN LOCALLY RESECTABLE ADVANCED ESOPHAGEAL SQUAMOUS CELL CARCINOMA. Diseases of the Esophagus. 35(Supplement_2). 5 indexed citations
6.
Song, Weian, et al.. (2020). Three-Field Lymphadenectomy in Minimally Invasive Esophagectomy for Squamous Cell Carcinoma. The Annals of Thoracic Surgery. 112(3). 928–934. 6 indexed citations
7.
Song, Weian, et al.. (2020). Salvage surgery for advanced non‐small cell lung cancer after targeted therapy: A case series. Thoracic Cancer. 11(4). 1061–1067. 18 indexed citations
8.
Su, Binbin, et al.. (2020). [Analysis of comorbidity and polypharmacy in middle-aged and elderly patients].. PubMed. 100(25). 1983–1987. 5 indexed citations
9.
Song, Weian, et al.. (2019). LINK‑A lncRNA is upregulated in metastatic non‑small cell lung cancer and is associated with poor prognosis. Oncology Letters. 18(3). 3049–3057. 9 indexed citations
10.
Wang, Wei, et al.. (2015). An Atypically Large, Free-Floating Thrombus Extending From the Lung to the Left Atrium via a Pulmonary Vein. Medicine. 94(46). e1853–e1853. 3 indexed citations
11.
Shang, Liqun, Jie Zhao, Wei Wang, et al.. (2014). [Inhibitory effect of endostar on lymphangiogenesis in non-small cell lung cancer and its effect on circulating tumor cells].. SHILAP Revista de lepidopterología. 17(10). 722–9. 7 indexed citations
12.
Chu, Xiangyang, et al.. (2011). Diagnostic values of SCC, CEA, Cyfra21-1 and NSE for lung cancer in patients with suspicious pulmonary masses: A single center analysis. Cancer Biology & Therapy. 11(12). 995–1000. 70 indexed citations
13.
Song, Weian, Xi Liu, Xiaodong Tian, et al.. (2011). Utility of squamous cell carcinoma antigen, carcinoembryonic antigen, Cyfra 21-1 and neuron specific enolase in lung cancer diagnosis: a prospective study from China.. PubMed. 124(20). 3244–8. 24 indexed citations
14.
Song, Weian, Naikang Zhou, Wei Wang, et al.. (2010). Survival Benefit of Neoadjuvant Chemotherapy in Non-small Cell Lung Cancer: An Updated Meta-Analysis of 13 Randomized Control Trials. Journal of Thoracic Oncology. 5(4). 510–516. 142 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026